The Jackson Laboratory (TJL) Cancer Center has 48 members organized into a single program, Gene Discovery and Analysis, Research focuses on genetic approaches for analyzing individual steps in the progression to cancer. In advancing this strategy, TJL researchers develop new tools for genetic analysis, which are used here and disseminated to the wider scientific community for work on the molecular and cellular bases of cancer. Virtually all TJL Cancer Center research uses genetically defined mice as the premier mammalian model for identifying and analyzing the genes that regulate these processes. Resources provided by the Cancer Center are the foundation of this research, supporting genome-scale gene discovery via QTL analysis, mutagenesis and positional cloning and functional analysis via gene targeting, transgenesis, phenotypic analyses, and expression arrays. The scientific leadership of TJL has direct oversight of the Cancer Center. Dr. Kenneth Paigen is the Director of TJL and the Cancer Center. Dr. Barbara Knowles, Associate Director of TJL and the Cancer Center, is also Director for Research at TJL and Program Leader at the Cancer Center. Support is requested for Scientific Resources and Services. Resources include the Mouse Models Resource, which provides spontaneous and induced mutant mice to Cancer Center staff, Cryopreservation and Rederivation Resource, for economical maintenance of strains at high health status, Veterinary Medicine Resource for ensuring animal health, the Diagnostic Laboratory Resource for consultation in clinical and anatomical pathology, and the Computational Biology Resource, which provides staff with access to expertise and analytical tools for advanced computational and statistical analysis. Scientific Services include Biological Imaging for complete histological analyses, Cell Biology and Microinjection for transgenic and targeted mutagenesis services, Flow Cytometry for a full suite of sorted and analysis services, and Microchemistry for molecular biological resources. Funds are requested for development of new techniques in these resources and services through a pilot program. Support is also requested for new investigators who will bring additional strength to the TJL Cancer Center's focus on mouse genomic and biological approaches to gene discovery in cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA034196-19
Application #
6367744
Study Section
Subcommittee G - Education (NCI)
Program Officer
Marino, Michael A
Project Start
1996-08-25
Project End
2006-07-31
Budget Start
2001-09-25
Budget End
2002-07-31
Support Year
19
Fiscal Year
2001
Total Cost
$2,451,222
Indirect Cost
Name
Jackson Laboratory
Department
Type
DUNS #
042140483
City
Bar Harbor
State
ME
Country
United States
Zip Code
04609
Becker, Timothy; Lee, Wan-Ping; Leone, Joseph et al. (2018) FusorSV: an algorithm for optimally combining data from multiple structural variation detection methods. Genome Biol 19:38
Wang, Qianghu; Hu, Baoli; Hu, Xin et al. (2018) Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell 33:152
Richter, Wolfgang F; Christianson, Gregory J; Frances, Nicolas et al. (2018) Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in mice. MAbs 10:803-813
Tamura, Ryo; Yoshihara, Kosuke; Saito, Tetsuya et al. (2018) Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions. Oncogenesis 7:4
Rutherford, Sarah C; Fachel, Angela A; Li, Sheng et al. (2018) Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations. Blood 132:e13-e23
Barthel, Floris P; Wesseling, Pieter; Verhaak, Roel G W (2018) Reconstructing the molecular life history of gliomas. Acta Neuropathol 135:649-670
Winer, Benjamin Y; Shirvani-Dastgerdi, Elham; Bram, Yaron et al. (2018) Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection. Sci Transl Med 10:
Kim, Hyunsoo; Kumar, Pooja; Menghi, Francesca et al. (2018) High-resolution deconstruction of evolution induced by chemotherapy treatments in breast cancer xenografts. Sci Rep 8:17937
Schechter, Lisa M; Creely, David P; Garner, Cherilyn D et al. (2018) Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in Escherichia coli. MBio 9:
Barthel, Floris P; Johnson, Kevin C; Wesseling, Pieter et al. (2018) Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults. Neurol Clin 36:421-437

Showing the most recent 10 out of 1156 publications